Watson pays $150 million upfront for Uteron Pharma

Watson Pharmaceuticals Inc has agreed to pay $150 million upfront for Uteron Pharma SA, a Belgian producer of healthcare products for women. The deal also includes up to $155 million in potential future milestone payments.